COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs

Vista sencilla de ítem
dc.date.accessioned2023-04-05T12:46:10Z
dc.date.available2023-04-05T12:46:10Z
dc.date.issued2021
dc.identifier.issn20499361
dc.identifier.urihttps://doi.org/10.1177/20499361211027065
dc.identifier.urihttp://146.190.124.33/handle/123456789/5995
dc.language.isoenges_ES
dc.publisherSAGE Publications Ltdes_ES
dc.sourceEducación Médica; Vol. 23 Núm. 5
dc.titleCOVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersion
Archivos
Colecciones
Editorial